Literature DB >> 2501812

Effects of D2 dopamine receptor blockade with raclopride on intracranial self-stimulation and food-reinforced operant behaviour.

S Nakajima1, J D Baker.   

Abstract

To examine the involvement of D2 dopamine receptors in the neural mechanism of reinforcement, raclopride tartrate, a D2 specific dopamine antagonist with a relatively fast central action, was injected into 32 rats. The D2 antagonist reduced bar-pressing responses reinforced with electrical stimulation of the ventral tegmental area (ED50 = 0.079 mumol/kg) and those reinforced with food (ED50 = 0.58 mumol/kg) in 18-30 min after IP injection. The reduction in response rates could not be attributed to an interference with motor functions. An increase in the frequency of brain-stimulation pulses and a change in the schedule of food reinforcement, which respectively increased the baseline rate of responding, did not alter the effectiveness of raclopride. SCH 23,390, a D1-specific dopamine antagonist, was sensitive to similar manipulation of reinforcement. These results seem to suggest that D1 and D2 antagonists may be acting at different locations in the neural mechanism underlying the reinforcement of operant behaviour.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501812     DOI: 10.1007/bf00451683

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist.

Authors:  F J White
Journal:  Eur J Pharmacol       Date:  1987-03-03       Impact factor: 4.432

2.  Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390.

Authors:  S Nakajima; G M McKenzie
Journal:  Pharmacol Biochem Behav       Date:  1986-04       Impact factor: 3.533

Review 3.  Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems.

Authors:  J L Waddington
Journal:  Biochem Pharmacol       Date:  1986-11-01       Impact factor: 5.858

4.  Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study.

Authors:  J H Carlson; D A Bergstrom; J R Walters
Journal:  Brain Res       Date:  1987-01-06       Impact factor: 3.252

5.  Dopamine D1 receptors in the nucleus accumbens: involvement in the reinforcing effect of tegmental stimulation.

Authors:  S Kurumiya; S Nakajima
Journal:  Brain Res       Date:  1988-05-10       Impact factor: 3.252

6.  Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.

Authors:  C Köhler; H Hall; S O Ogren; L Gawell
Journal:  Biochem Pharmacol       Date:  1985-07-01       Impact factor: 5.858

7.  Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behaviour and catalepsy in rats: behavioural profile comparisons between raclopride, haloperidol and preclamol.

Authors:  V Hillegaart; S Ahlenius
Journal:  Pharmacol Toxicol       Date:  1987-05

8.  Affinity for the dopamine D2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation.

Authors:  C R Gallistel; A J Davis
Journal:  Pharmacol Biochem Behav       Date:  1983-11       Impact factor: 3.533

9.  Intravenous self-administration of dopamine receptor agonists by rhesus monkeys.

Authors:  W L Woolverton; L I Goldberg; J Z Ginos
Journal:  J Pharmacol Exp Ther       Date:  1984-09       Impact factor: 4.030

10.  Quantitative determination of the effects of catecholaminergic agonists and antagonists on the rewarding efficacy of brain stimulation.

Authors:  C R Gallistel; G Freyd
Journal:  Pharmacol Biochem Behav       Date:  1987-04       Impact factor: 3.533

View more
  6 in total

1.  Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice.

Authors:  G I Elmer; J O Pieper; J Levy; M Rubinstein; M J Low; D K Grandy; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

2.  Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food.

Authors:  S B Caine; G F Koob
Journal:  J Exp Anal Behav       Date:  1994-03       Impact factor: 2.468

3.  Neuropharmacological evidence for the role of dopamine in ventral pallidum self-stimulation.

Authors:  G Panagis; C Spyraki
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

4.  Cocaine facilitation of prefrontal cortex self-stimulation: a microstructural and pharmacological analysis.

Authors:  I S McGregor; D M Atrens; D M Jackson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Dopamine D1 and D2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats.

Authors:  R Ranaldi; R J Beninger
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 6.  To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making.

Authors:  Giovanni Hernandez; Joseph F Cheer
Journal:  Front Behav Neurosci       Date:  2015-12-17       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.